步长脑心通胶囊对高血压性脑梗死恢复期患者纤维蛋白原和血清超敏C反应蛋白含量的影响  

Influence of Naoxintong capsule on FIB and hsCRP in patients with recovery phase of hypertension-cerebral infarction

作　　者：姜文大[1] 臧丽娥[1] 隋汝波[1] 

机构地区：[1]辽宁医学院附属第一医院神经内科,辽宁锦州121000

出　　处：《实用临床医药杂志》2011年第23期77-79,共3页Journal of Clinical Medicine in Practice

摘　　要：目的探讨步长脑心通胶囊对高血压性脑梗死恢复期患者纤维蛋白原和血清超敏C反应蛋白含量的影响。方法选择高血压性脑梗死恢复期患者160例,随机分为观察组80例及对照组80例,对照组予常规治疗,观察组在常规治疗基础上加用步长脑心通胶囊。观察期为3个月,比较治疗前后纤维蛋白原(FIB)和血清超敏C反应蛋白(hsCRP)含量。结果对照组治疗前后FIB和血清hsCRP含量无明显变化,观察组治疗后FIB和血清hsCRP含量明显下降,差异有统计学意义(P<0.01)。结论对于高血压性脑梗死恢复期患者应用脑心通胶囊治疗,有利于降低FIB浓度,减轻炎症反应和神经损伤程度,更好地预防脑梗死复发。Objective To explore the influence of Naoxintong capsule on FIB and hsCRP in patients with recovery phase of hypertension- cerebral infarction. Methods One hundred and sixty cases of hypertension - cerebral infarction were divided into treatment group （ n = 80） and control group （n = 80）. The control group received routine therapy, and the treatment group was added with Naoxintong capsule. The observation period was three months. The levels of fibrinogen （FIB） and hsCRP before and after therapy were contrasted. Results There was no significant difference of levels of FIB and hsCRP in control group between before therapy and after therapy. The levels of FIB and hsCRP of the treatment group, after therapy were obviously lower than those before therapy （P 〈 0.01 ）. Conclusion Application of Naoxintong capsule patients with recovery phase of hyper- tension - cerebral infarction contributes to decreasing the levels of FIB, lightening the inflammatory reactions and nerve injury, and can better prevent recurring of cerebral infarction.

关 键 词：急性脑梗死 脑心通胶囊 纤维蛋白原 超敏C反应蛋白 

分 类 号：R743.33[医药卫生—神经病学与精神病学]